drugset / Trial / NCT04752475

Lasix for the Prevention of De Novo Postpartum Hypertension

NCT04752475

Phase 3 Completed 82 enrolled Columbia University
RandomizedParallel-groupTriple-blindPrevention

Summary

Primary objective: To evaluate whether oral furosemide can help prevent de novo postpartum hypertension (new-onset high blood pressure after delivery) by reducing blood pressure after delivery in high-risk women. Secondary objectives: To evaluate whether oral furosemide administered to high-risk women after delivery can reduce the frequency of postpartum hypertensive episodes, the need for antihypertensive therapy, the risk of postpartum preeclampsia, and the incidence of severe maternal morbidity.

Timeline

Start
2021-10-20
Primary completion
2022-04-18
Completion
2022-05-28

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Furosemide Other / unclassified 20 mg Oral

Indications